Never miss an important update on your stock portfolio and cut through the noise. Over 7 million investors trust Simply Wall St to stay informed where it matters for FREE.
Tasmea (ASX:TEA) has applied to the ASX for quotation of 5,006 new fully paid ordinary shares issued under its Bonus Share Plan for senior employees, highlighting its equity-based incentive approach.
See our latest analysis for Tasmea.
The A$4.56 share price sits against a mixed recent pattern, with a 10.68% 7 day share price return and an 8.83% year to date share price return. The 1 year total shareholder return of 63.41% suggests momentum has been building over a longer period.
If Tasmea's recent move on equity incentives has caught your attention, it could be a good moment to broaden your watchlist and check out aerospace and defense stocks as another source of ideas.
With A$4.56 per share, solid recent returns and an indicated intrinsic discount of about 45%, the key question is whether Tasmea still offers value, or if the market is already pricing in further growth.
Price-to-Earnings of 22.4x: Is it justified?
Tasmea is trading on a P/E of 22.4x, which sits against an SWS fair P/E estimate of 23.6x and a last close of A$4.56.
The P/E multiple compares the current share price to earnings per share, so it gives you a quick read on how much investors are paying for each dollar of profit.
For Tasmea, our data suggests this earnings based valuation is broadly aligned with what the SWS fair P/E implies the market could move toward over time.
Compared with peers, the picture is mixed. Tasmea's 22.4x P/E is below the peer average of 30.5x, which suggests the market is applying a lower earnings multiple than many similar companies. However, it is above the 15.5x average for the global construction industry, which points to investors paying a premium versus the wider sector.
Explore the SWS fair ratio for Tasmea
Result: Price-to-Earnings of 22.4x (ABOUT RIGHT)
However, the story can change quickly if earnings soften or if Tasmea's exposure to mining, oil and gas, and infrastructure projects faces delays or reduced activity.
Find out about the key risks to this Tasmea narrative.
Another View: What Does The DCF Say?
Our DCF model points to a fair value of A$8.29 per share for Tasmea, compared with the current A$4.56 price. That implies the shares are trading at a sizeable discount, even after the recent strong 1 year total return. This raises a simple question: is the market too cautious or is the model too generous?
Look into how the SWS DCF model arrives at its fair value.
Simply Wall St performs a discounted cash flow (DCF) on every stock in the world every day ( check out Tasmea for example ). We show the entire calculation in full. You can track the result in your watchlist or portfolio and be alerted when this changes, or use our stock screener to discover 868 undervalued stocks based on their cash flows . If you save a screener we even alert you when new companies match - so you never miss a potential opportunity.
Build Your Own Tasmea Narrative
If you see the numbers differently, or prefer to dig into the data yourself, you can shape your own Tasmea story in minutes, starting with Do it your way .
A great starting point for your Tasmea research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
Looking for more investment ideas?
If Tasmea is on your radar, do not stop there. Use the Simply Wall Street Screener to quickly surface fresh ideas that match your style and goals.
-
Hunt for potential value by scanning these 868 undervalued stocks based on cash flows that currently trade below what their cash flows suggest.
-
Spot emerging themes in healthcare by checking out these 108 healthcare AI stocks that blend medical applications with AI tools.
-
Lean into volatility with these 80 cryptocurrency and blockchain stocks tied to cryptocurrency and blockchain trends if you are comfortable with higher risk.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include TEA.AX .
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
